Gelatinases and their inhibitors in tumor metastasis: From biological research to medical applications

Histology and Histopathology

Volumn 17, Issue 1, 2002, Pages 339-345

  Giannelli, Gianluigi ^a   Antonaci, S ^a  

^a POLICLINICO   (Italy)

Author keywords

Cancer; Gelatinases; Inhibitors; Matrix metalloproteinases; Metastasis

Indexed keywords

BATIMASTAT; CYTOKINE; EPIGALLOCATECHIN GALLATE; GELATINASE; GELATINASE A; GELATINASE B; GELATINASE INHIBITOR; GROWTH FACTOR; MARIMASTAT; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

BASEMENT MEMBRANE; CANCER; CANCER CELL; CANCER INVASION; CANCER TISSUE; CYTOKINE RELEASE; DISEASE COURSE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; GENE THERAPY; HUMAN; MEDICAL RESEARCH; METASTASIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SIDE EFFECT;

ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; GELATINASES; HUMANS; METALLOENDOPEPTIDASES; NEOPLASM METASTASIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0036165030     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Stromelysin-1 regulates adipogenesis during mammary gland involution
2. Cancer proteomics: From biomarker discovery to signal pathway profiling
3. Proteolytic remodeling of extracellular matrix
4. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinase-2 into the liver tissue
5. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling
6. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
7. Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20
8. Membrane proteases: Roles in tissue remodeling and tumour invasion
9. Matrix metalloproteinases and the development of cancer
10. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices
11. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate
12. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma
13. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
14. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids
15. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma
16. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion
17. The role of tissue microdissection in cancer research
18. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension
19. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model
20. Elevated levels of circulating plasma matrix metalloproteinase 9 in non- small cell lung cancer patients
21. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture
22. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinase (TIMP)-2 by 4-aminophenylmercuric acetate
23. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
24. Molecular insights into cancer invasion: Strategies for prevention and intervention
25. Tumor targeting with a selective gelatinase inhibitor
26. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
27. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression
28. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species
29. The microenvironment of the tumour-host interface
30. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
31. Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrini-mediated cell adhesion
32. Analysis of MT1-MMP and MMP2 expression in human gastric cancers
33. A novel protease-docking function of integrin at invadopodia
34. Cell surface activation of progelatinase A (proMMP-2) and cell migration
35. Matrix metalloproteinases
36. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors
37. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas
38. The mammary fat pad
39. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells
40. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
41. Gelatinase A activity directly modulates melanoma cell adhesion and spreading
42. A matrix metalloproteinase expressed on the surface of invasive tumour cells
43. Tumor cell interactions with the extracellular matrix during invasion and metastasis
44. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
45. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
46. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
47. Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue
48. Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma
49. Tea and cancer
50. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly